MedPath

Efficacy of medicated herbal lepa in hyperpigmentation management

Phase 2
Conditions
Health Condition 1: L814- Other melanin hyperpigmentation
Registration Number
CTRI/2024/07/071662
Lead Sponsor
ational Institute of Ayurveda Deemed to be university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients presenting Vyanga as clinical features according to Susruta Samhita (Mandalam Visrujati, Nirujam Tanu ,Shyava).

2.

Patients of either sex.

3.

Patients of age between 18 - 60 years.

4.

Patients that come under the criteria of MASI scale.

Exclusion Criteria

Melasma due to tubercular therapy or malignant cases.

2.

Patients having systemic pathogenesis due to allergy.

3.

Diagnosed patients of Carcinoma, Burns, Herpes, Eczema, Psoriasis, Measles, Chickenpox, Leucoderma and Leprosy.

4.

Person suffering from any infective or contagious skin disease or under medication with antibiotics, antifungal and steroid.

5.

Patients of uncontrolled hormonal disease.

6.

Patients who are reporting allergic history of trial drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath